Showing results (71-80 of 145) with videos related to

Sort By:
Pageof 15
Tumori|August 12, 2003
Surgical management of cerebral metastases from non-small cell lung cancerAngelos K Koutras, Markos Marangos, Theodoros Kourelis, et al.
Journal of the Peripheral Nervous System : JPNS|February 4, 2024
Incidence and risk factors for developing chemotherapy-induced neuropathic pain in 500 cancer patients: A file-based observational studyAndreas A Argyriou, Jordi Bruna, Foteini Kalofonou, et al.
Sarcoma|June 4, 2008
A Phase II Study of Docetaxel and Epirubicin in Advanced Adult Soft Tissue Sarcomas (STS)Haralabos P Kalofonos, Charalabos Kourousis, Michalis V Karamouzis, et al.
Virchows Archiv : an International Journal of Pathology|July 20, 2011
Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomasDionysios J Papachristou, Angeliki Korpetinou, Efstathia Giannopoulou, et al.
Genes|November 27, 2021
RANK-C Expression Sensitizes ER-Negative, EGFR-Positive Breast Cancer Cells to EGFR-Tyrosine Kinase Inhibitors (TKIs)Chaido Sirinian, Anastasios D Papanastasiou, Soren E Degn, et al.
Anticancer Research|May 28, 2011
Association of FOXP3 expression with non-small cell lung cancerFotinos-Ioannis D Dimitrakopoulos, Helen Papadaki, Anna G Antonacopoulou, et al.
Breast Cancer Research and Treatment|December 3, 2005
Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 womenGeorge Pentheroudakis, George Fountzilas, Dimitrios Bafaloukos, et al.
Cancer Chemotherapy and Pharmacology|February 18, 2015
A pharmacokinetic binding model for bevacizumab and VEGF165 in colorectal cancer patientsEirini Panoilia, Emilie Schindler, Epaminontas Samantas, et al.
Acta Histochemica|November 23, 2011
Altered expression of NFY-C and RORA in colorectal adenocarcinomasAnastasia E Kottorou, Anna G Antonacopoulou, Fotinos-Ioannis D Dimitrakopoulos, et al.
Translational Oncology|October 19, 2020
NF-κB2 and RELB offer prognostic information in colorectal cancer and NFKB2 rs7897947 represents a genetic risk factor for disease developmentAnna Antonacopoulou, Anastasia E Kottorou, Foteinos-Ioannis Dimitrakopoulos, et al.
Pageof 15